Clinical Trial Update: Evaluation of the Safety, Tolerability and Pharmacokinetics of Repeat Oral Doses of GSK962040 Administered to Healthy Adult Subjects. [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating the safety, tolerability and pharmacokinetics of repeat oral doses of GSK962040 in healthy adults; Gastroparesis is listed as the condi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastroparesis

Drugs mentioned

• GSK962040

Snippet

Sponsor: GlaxoSmithKline | Conditions: Gastroparesis | Phase 1 | Status: COMPLETED